Anti-CD19 CAR T-Cell Therapy for Adult Patients With Refractory Large B-Cell Lymphoma

Chimeric antigen receptor (CAR) T-cell therapies represent a new paradigm in targeted cancer therapy. T cells play a key role in immune surveillance, but tumors have developed multiple mechanisms for evading that surveillance. CAR T-cell technology aims to enhance the innate ability of the body to f...

Descripción completa

Detalles Bibliográficos
Autores principales: McDermott, Kathleen, Spendley, Lauren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521124/
https://www.ncbi.nlm.nih.gov/pubmed/33520342
http://dx.doi.org/10.6004/jadpro.2019.10.4.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521124/
https://www.ncbi.nlm.nih.gov/pubmed/33520342
http://dx.doi.org/10.6004/jadpro.2019.10.4.10

Ejemplares similares